Literature DB >> 32222191

COVID-19 cacophony: is there any orchestra conductor?

Antoine Flahault1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32222191      PMCID: PMC7194627          DOI: 10.1016/S0140-6736(20)30491-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
The first wave of coronavirus disease 2019 (COVID-19) pandemic is currently invading the world, and several countries are now struggling to fight it or trying to delay its start to help smooth its peak size for the purpose of lowering morbidity and mortality, and thereby reduce the overall tension on their health-care system. China's first major outbreaks of COVID-19 happened in January, 2020. Then South Korea, Iran, and Italy entered into this Ravel's Bolero-like epidemic in late February and early March, 2020, and many other countries are preparing to play the same rhythmic pattern in the coming days and weeks. All countries have to react and take action without any conducting from WHO. WHO's Director-General declared on Jan, 30, 2020, a Public Health Emergency of International Concern, which allowed him to release subsequent recommendations, but none were issued with regard to what to do, and when to do it, at the country level. With no vaccine or antivirals, the portfolio of countermeasures against COVID-19 is limited. Only a small set of evidence-based non-pharmaceutical interventions are available.2, 3, 4, 5, 6 Measures like self-quarantine, or temperature control at borders, are not expected to be very effective since half of infections are asymptomatic. There is consensus today to propose school closure, restrict social gathering (including shutdown of workplaces), limit population movements, and introduce so-called cordons sanitaires, which means quarantines at the scale of cities or regions. There is less consensus about which measure should start first, in which combination, and when. There is no direct scientific evidence regarding wearing protective masks in public spaces for asymptomatic people, but mask protection is heavily practised in Asian populations and seems deeply despised in Western cultures. There is no common policy about which measures should be considered, and at which epidemiological threshold such measures should be implemented. Nobody knows at which level restrictions on mass gathering should be imposed. The recent Chinese experience of combining non-pharmaceutical interventions to curb outbreak trends seems rather convincing. Although starting late in the process, authoritarian Chinese authorities succeeded in combining forced isolation of the population with all available social distancing interventions. The democratic Italian Government, followed by the governments of France, Spain, and other countries, set up most of these measures quickly in the epidemic process but lacked any international guidance or recommendations. Would they not have expected to see WHO headquarters as the orchestra conductor at this stage of the process? Do Member States not need some level of harmonisation and coordination when implementing the four available non-pharmaceutical interventions; to help them decide whether, when, and how to implement them; if, when, and how to combine them; and to what extent? In addition, the Chinese Government has no guidance nor recommendation about lifting measures that have been in place in Wuhan since Jan 23, 2020. To what extent, at which pace, and how should they start lifting their intervention and allow people to resume normal social and economic life? WHO remains surprisingly silent and absent in all of these pragmatic questions.
  4 in total

1.  Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic.

Authors:  Howard Markel; Harvey B Lipman; J Alexander Navarro; Alexandra Sloan; Joseph R Michalsen; Alexandra Minna Stern; Martin S Cetron
Journal:  JAMA       Date:  2007-08-08       Impact factor: 56.272

2.  Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic.

Authors:  Michael J Haber; David K Shay; Xiaohong M Davis; Rajan Patel; Xiaoping Jin; Eric Weintraub; Evan Orenstein; William W Thompson
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

3.  Non-pharmaceutical interventions for pandemic influenza, international measures.

Authors:  David Bell; Angus Nicoll; Keiji Fukuda; Peter Horby; Arnold Monto; Frederick Hayden; Clare Wylks; Lance Sanders; Jonathan Van Tam
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

4.  Non-pharmaceutical interventions for pandemic influenza, national and community measures.

Authors:  David Bell; Angus Nicoll; Keiji Fukuda; Peter Horby; Arnold Monto; Frederick Hayden; Clare Wylks; Lance Sanders; Jonathan van Tam
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

  4 in total
  10 in total

1.  Principalism in public health decision making in the context of the COVID-19 pandemic.

Authors:  Paulo Ferrinho; Mohsin Sidat; Gisela Leiras; Fernando Passos Cupertino de Barros; Horácio Arruda
Journal:  Int J Health Plann Manage       Date:  2020-07-10

2.  Countermeasures against COVID-19: how to navigate medical practice through a nascent, evolving evidence base - a European multicentre mixed methods study.

Authors:  Fabian Eibensteiner; Valentin Ritschl; Tanja Stamm; Asil Cetin; Claus Peter Schmitt; Gema Ariceta; Sevcan Bakkaloglu; Augustina Jankauskiene; Günter Klaus; Fabio Paglialonga; Alberto Edefonti; Bruno Ranchin; Rukshana Shroff; Constantinos J Stefanidis; Johan Vandewalle; Enrico Verrina; Karel Vondrak; Aleksandra Zurowska; Seth L Alper; Christoph Aufricht
Journal:  BMJ Open       Date:  2021-02-17       Impact factor: 2.692

Review 3.  COVID-19 illness and autoimmune diseases: recent insights.

Authors:  Juan Li; Hong-Hui Liu; Xiao-Dong Yin; Cheng-Cheng Li; Jing Wang
Journal:  Inflamm Res       Date:  2021-02-28       Impact factor: 4.575

Review 4.  Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice.

Authors:  P Gisondi; S Piaserico; A Conti; L Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06       Impact factor: 9.228

5.  COVID-19: The Waterloo of governments, healthcare systems, and large health organizations.

Authors:  Michael Douma; Konstantinos P Imprialos; Dimitrios Patoulias; Alexandra Katsimardou; Konstantinos Stavropoulos
Journal:  Eur J Intern Med       Date:  2020-06-02       Impact factor: 4.487

6.  Minimizing the risk of COVID-19 among patients on dialysis.

Authors:  T Alp Ikizler; Alan S Kliger
Journal:  Nat Rev Nephrol       Date:  2020-06       Impact factor: 28.314

Review 7.  Bioactive natural compounds against human coronaviruses: a review and perspective.

Authors:  Yanfang Xian; Juan Zhang; Zhaoxiang Bian; Hua Zhou; Zhenbiao Zhang; Zhixiu Lin; Hongxi Xu
Journal:  Acta Pharm Sin B       Date:  2020-06-08       Impact factor: 11.413

8.  Surgery at the frontline at the time of the COVID-19 outbreak.

Authors:  Alberto Testori; Ugo Cioffi; Michele M Ciulla; Edoardo Bottoni; Umberto Cariboni; Gianluca Perroni; Marco Alloisio
Journal:  Thorac Cancer       Date:  2020-09-16       Impact factor: 3.500

9.  COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios.

Authors:  Henrik Sjödin; Anders F Johansson; Åke Brännström; Zia Farooq; Hedi Katre Kriit; Annelies Wilder-Smith; Christofer Åström; Johan Thunberg; Mårten Söderquist; Joacim Rocklöv
Journal:  Int J Epidemiol       Date:  2020-10-01       Impact factor: 7.196

10.  Perceptions, emotional reactions and needs of adolescent psychiatric inpatients during the COVID-19 pandemic: a qualitative analysis of in-depth interviews.

Authors:  George Giannakopoulos; Savvina Mylona; Anastasia Zisimopoulou; Maria Belivanaki; Stella Charitaki; Gerasimos Kolaitis
Journal:  BMC Psychiatry       Date:  2021-07-28       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.